Piscataway, NJ, January 19, 2022–Camber Pharmaceuticals is pleased to announce the addition of Colchicine Tablets to their current portfolio.
Colchicine Tablets are an alkaloid indicated for Prophylaxis and treatment of gout flares in adults and Familial Mediterranean fever (FMF) in adults and children 4 years or older.
Camber Colchicine 0.6 mg Tablets are available in 30 and 100 count bottles.
To find out more about Colchicine Tablets please visit https://www.camberpharma.com
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
- 28 New Generics in 2022 and Anticipates Record Number of Approvals in 2023
- Camber Pharmaceuticals Launches Generic Cambia®
- Camber Pharmaceuticals Launches Generic Kuvan® Tablets and Powder for Oral Solution
- Camber Pharmaceuticals Launches Generic Vimpat® Injection
- Camber Pharmaceuticals Launches Generic Naprosyn®
- Camber Pharmaceuticals Launches Generic Lamictal XR®